新生体免疫模仿增强乳腺瘤的进展
Eric B Berens1, Sokchea Khou2, Elaine T Huang3
1Oregon Health and Science University Hospital, Portland, United States.
Cancer research
|October 23, 2025
概括
乳腺癌细胞可以模仿免疫细胞,一种称为"免疫模仿"的过程,使其变得更具攻击性和耐治疗性. 这一发现可能有助于预测患者的结果,并对癌症护理进行分层.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤脱差增强了癌细胞的健康状况,增加了攻击性和治疗抵抗力.
- 瘤中的细胞可塑性与预后不佳和转移相关.
- 新生细胞可以在癌症进展过程中采用非上皮特征.
研究的目的:
- 识别和描述乳腺癌细胞中一种新的脱差程序,称为"免疫模仿".
- 调查免疫模拟在乳腺癌攻击性,治疗耐药性和转移潜力的作用.
- 探索免疫仿真对患者预后和分层的临床实用性.
主要方法:
- 对人类乳腺瘤单细胞RNA测序数据和组织病理学标本的分析.
- 使用乳腺癌细胞系进行体外功能实验.
- 在小鼠转基因和细胞系衍生乳腺癌模型中的体内研究.
- 研究了细胞毒性化疗对上皮细胞脱差的影响.
主要成果:
- 不分化乳腺癌细胞的子群体表达白细胞细胞表面受体,表现出"免疫模仿".
- 免疫模仿细胞表现出脱差特征,并富含耐治疗,高度瘤.
- 细胞毒性化疗驱使侵袭性乳腺癌细胞向免疫模仿.
- 瘤细胞表达CD69 (白细胞激活蛋白) 促进瘤生长.
结论:
- 新生体乳腺上皮细胞调节白细胞表面受体,有助于恶性瘤.
- 免疫模仿是一种与侵袭性乳腺癌表型相关的脱差程序.
- 免疫仿真对乳腺癌患者的预后和治疗分层具有潜在的临床实用性.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


